Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.04.2021 | Case report

Amiodarone/norepinephrine/tocilizumab

Inflammatory perimyocarditis, pulmonary intravascular coagulopathy following off-label use, and lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Bovet M, et al. Fatal course of COVID-19 despite IL-6 receptor blockade in cytokine storm: Perimyocarditis and coagulopathy after administration of tocilizumab. Anaesthesist 70: 121-126, No. 2, Feb 2021. Available from: URL: http://doi.org/10.1007/s00101-020-00871-x [German; summarised from a translation] Bovet M, et al. Fatal course of COVID-19 despite IL-6 receptor blockade in cytokine storm: Perimyocarditis and coagulopathy after administration of tocilizumab. Anaesthesist 70: 121-126, No. 2, Feb 2021. Available from: URL: http://​doi.​org/​10.​1007/​s00101-020-00871-x [German; summarised from a translation]
Metadaten
Titel
Amiodarone/norepinephrine/tocilizumab
Inflammatory perimyocarditis, pulmonary intravascular coagulopathy following off-label use, and lack of efficacy: case report
Publikationsdatum
01.04.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-93831-x

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Multiple drugs

Case report

Heparin